USPTO 2015–2025 USPTO PatentsView US Corporation

Carefusion 2200, Inc.

USPTO PatentsView assignee record - 97 granted patents across 35 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

18.5

Avg claims per patent

-44%

5-year filing velocity

The verdict

Carefusion holds 97 US patents across 35 technology areas, rank #3,728 of 50,000 tracked assignees.

#3,728
of 50,000 US assignees by volume: Top 12%
by Innovation Score (51.0/100): 18.5
avg claims per patent: -44%
filing velocity, last 5 yrs

Portfolio overview

Carefusion 2200, Inc. has been granted 97 US utility patents between 2015 and 2025, placing Carefusion 2200, Inc. at rank #3,728 across all assignees tracked by PlainPatent. This portfolio spans 35 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.5 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Carefusion 2200, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Carefusion sits between Arlo Technologies, Inc. (97 patents, rank #3,724) and Eppendorf Ag (97 patents, rank #3,732) - the closest US assignees by grant volume. The composite Innovation Score of 51.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 35 grants, compared with 62 in the 2015–2019 window, a -44% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Carefusion 2200, Inc.'s 18.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 35 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Carefusion 2200, Inc. against peers pursuing similar technology classes.

Arlo

97
Bulgari S P A

97
Berlin Packaging

97
CREO Medical

97
Dongguan Jiasheng…

97
DSP Group

97
Dynasty Footwear

97
Eppendorf

97
Carefusion 2200 ◀

97

What this shows Carefusion holds 97 patents at rank #3,728, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Carefusion

By rank, the assignees closest to #3,728 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Carefusion's primary technology class.

Carefusion's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

51 Top 12% higher than 88% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Carefusion 2200, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	16	16.5%
2016	11	11.3%
2017	14	14.4%
2018	7	7.2%
2019	14	14.4%
2020	11	11.3%
2021	5	5.2%
2022	5	5.2%
2023	4	4.1%
2024	5	5.2%
2025	5	5.2%

Which technologies does Carefusion 2200, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 43

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 40

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 14

A01N - PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS 9

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 8

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 6

B26B - HAND-HELD CUTTING TOOLS NOT OTHERWISE PROVIDED FOR 5

A61Q - SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS 4

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 4

A47L - DOMESTIC WASHING OR CLEANING ; SUCTION CLEANERS IN GENERAL 3

A01P - BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS 3

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 3

F16B - DEVICES FOR FASTENING OR SECURING CONSTRUCTIONAL ELEMENTS OR MACHINE PARTS TOGETHER, e.g. NAILS, BOLTS, CIRCLIPS, CLAMPS, CLIPS OR WEDGES; JOINTS OR JOINTING 2

F16K - VALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING 2

C08L - COMPOSITIONS OF MACROMOLECULAR COMPOUNDS 2

Top 15 of 35 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#3,728

Across all tracked assignees

Innovation Score

51.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Carefusion 2200, Inc. hold?

Carefusion 2200, Inc. holds 97 US granted patents filed between 2015 and 2025, spanning 35 technology areas.

What is Carefusion 2200, Inc.'s Innovation Score?

Carefusion 2200, Inc. has an Innovation Score of 51.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Carefusion 2200, Inc. focus on?

Carefusion 2200, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 43 patents. The company has filed patents in 35 CPC subclasses total.

Is Carefusion 2200, Inc.'s patent filing rate increasing or decreasing?

Carefusion 2200, Inc.'s recent filing velocity is -44% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Carefusion 2200, Inc.'s patents?

Carefusion 2200, Inc.'s patents average 18.5 claims each. This falls within the standard range, providing solid legal coverage.

How is the Carefusion 2200, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Carefusion's 97 grants land it in the top 12% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Carefusion ranks #3,728 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.